Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 28

1.

Reliability of adverse symptom event reporting by clinicians.

Atkinson TM, Li Y, Coffey CW, Sit L, Shaw M, Lavene D, Bennett AV, Fruscione M, Rogak L, Hay J, Gönen M, Schrag D, Basch E.

Qual Life Res. 2012 Sep;21(7):1159-64. doi: 10.1007/s11136-011-0031-4. Epub 2011 Oct 8.

2.

Safety reporting and adverse-event profile of mirtazapine described in randomized controlled trials in comparison with other classes of antidepressants in the acute-phase treatment of adults with depression: systematic review and meta-analysis.

Watanabe N, Omori IM, Nakagawa A, Cipriani A, Barbui C, McGuire H, Churchill R, Furukawa TA; MANGA (Meta-Analysis of New Generation Antidepressants) Study Group.

CNS Drugs. 2010 Jan;24(1):35-53. doi: 10.2165/11319480-000000000-00000. Review.

PMID:
20030418
3.

The association between clinician-based common terminology criteria for adverse events (CTCAE) and patient-reported outcomes (PRO): a systematic review.

Atkinson TM, Ryan SJ, Bennett AV, Stover AM, Saracino RM, Rogak LJ, Jewell ST, Matsoukas K, Li Y, Basch E.

Support Care Cancer. 2016 Aug;24(8):3669-76. doi: 10.1007/s00520-016-3297-9. Epub 2016 Jun 3. Review.

PMID:
27260018
5.

Cochrane Review: Osmotic and stimulant laxatives for the management of childhood constipation (Review).

Gordon M, Naidoo K, Akobeng AK, Thomas AG.

Evid Based Child Health. 2013 Jan;8(1):57-109. doi: 10.1002/ebch.1893. Review.

PMID:
23878124
6.

Impact of morphine, fentanyl, oxycodone or codeine on patient consciousness, appetite and thirst when used to treat cancer pain.

Wiffen PJ, Derry S, Moore RA.

Cochrane Database Syst Rev. 2014 May 29;(5):CD011056. doi: 10.1002/14651858.CD011056.pub2. Review.

PMID:
24874470
7.

A rapid and systematic review of the clinical effectiveness and cost-effectiveness of topotecan for ovarian cancer.

Forbes C, Shirran L, Bagnall AM, Duffy S, ter Riet G.

Health Technol Assess. 2001;5(28):1-110. Review.

8.

Cannabinoids for nausea and vomiting in adults with cancer receiving chemotherapy.

Smith LA, Azariah F, Lavender VT, Stoner NS, Bettiol S.

Cochrane Database Syst Rev. 2015 Nov 12;(11):CD009464. doi: 10.1002/14651858.CD009464.pub2. Review.

PMID:
26561338
9.

Selective serotonin reuptake inhibitors for premenstrual syndrome.

Marjoribanks J, Brown J, O'Brien PM, Wyatt K.

Cochrane Database Syst Rev. 2013 Jun 7;(6):CD001396. doi: 10.1002/14651858.CD001396.pub3. Review.

PMID:
23744611
10.

Supporting quality and patient safety in cancer clinical trials.

Badalucco S, Reed KK.

Clin J Oncol Nurs. 2011 Jun;15(3):263-5. doi: 10.1188/11.CJON.263-265. Review.

PMID:
21624861
11.

Antipsychotics for fibromyalgia in adults.

Walitt B, Klose P, Üçeyler N, Phillips T, Häuser W.

Cochrane Database Syst Rev. 2016 Jun 2;(6):CD011804. doi: 10.1002/14651858.CD011804.pub2. Review.

PMID:
27251337
12.

Sublingual immunotherapy for asthma.

Normansell R, Kew KM, Bridgman AL.

Cochrane Database Syst Rev. 2015 Aug 28;(8):CD011293. doi: 10.1002/14651858.CD011293.pub2. Review.

PMID:
26315994
13.

Under-reporting of harm in clinical trials.

Seruga B, Templeton AJ, Badillo FE, Ocana A, Amir E, Tannock IF.

Lancet Oncol. 2016 May;17(5):e209-19. doi: 10.1016/S1470-2045(16)00152-2. Epub 2016 Apr 27. Review.

PMID:
27301048
14.

Screening for prostate cancer.

Ilic D, Neuberger MM, Djulbegovic M, Dahm P.

Cochrane Database Syst Rev. 2013 Jan 31;(1):CD004720. doi: 10.1002/14651858.CD004720.pub3. Review.

PMID:
23440794
15.

Antioxidants for male subfertility.

Showell MG, Mackenzie-Proctor R, Brown J, Yazdani A, Stankiewicz MT, Hart RJ.

Cochrane Database Syst Rev. 2014;(12):CD007411. doi: 10.1002/14651858.CD007411.pub3. Epub 2014 Dec 15. Review.

PMID:
25504418
16.

Massage with or without aromatherapy for symptom relief in people with cancer.

Shin ES, Seo KH, Lee SH, Jang JE, Jung YM, Kim MJ, Yeon JY.

Cochrane Database Syst Rev. 2016 Jun 3;(6):CD009873. doi: 10.1002/14651858.CD009873.pub3. Review.

PMID:
27258432
17.

Patient-reported outcomes in the evaluation of toxicity of anticancer treatments.

Di Maio M, Basch E, Bryce J, Perrone F.

Nat Rev Clin Oncol. 2016 May;13(5):319-25. doi: 10.1038/nrclinonc.2015.222. Epub 2016 Jan 20. Review.

18.

The measurement and monitoring of surgical adverse events.

Bruce J, Russell EM, Mollison J, Krukowski ZH.

Health Technol Assess. 2001;5(22):1-194. Review.

19.

Aminosalicylates for induction of remission or response in Crohn's disease.

Lim WC, Wang Y, MacDonald JK, Hanauer S.

Cochrane Database Syst Rev. 2016 Jul 3;7:CD008870. doi: 10.1002/14651858.CD008870.pub2. Review.

PMID:
27372735
20.

Standardizing assessment and reporting of adverse effects in rheumatology clinical trials II: the Rheumatology Common Toxicity Criteria v.2.0.

Woodworth T, Furst DE, Alten R, Bingham CO 3rd, Yocum D, Sloan V, Tsuji W, Stevens R, Fries J, Witter J, Johnson K, Lassere M, Brooks P.

J Rheumatol. 2007 Jun;34(6):1401-14. Erratum in: J Rheumatol. 2014 Nov;41(11):2336. Bingham, Clifton [corrected to Bingham, Clifton O 3rd].

PMID:
17552067

Supplemental Content

Support Center